"Her Power" | Four female equity fund managers from Huashang Fund meet the era with professionalism

At Huashang Fund, there is a group of female fund managers who rely on knowledge and wield professionalism as their blades. They delve deeply into diverse investment fields such as equities, fixed income, high-end manufacturing, technology, pharmaceuticals, and cyclical industries. They incorporate women’s sensitivity, resilience, and wisdom into every investment decision, continuously striving to create wealth alpha for investors. The brand spirit of Huashang Fund—“Professional, Proactive, Honest, Innovative, Responsible”—becomes even more vibrant through their blossoming.

Xiao Zhang

Master’s in Economics, Peking University

Fund Manager of Huashang Medical & Healthcare Equity Fund

Fund Manager of Huashang Hengyi Stable Hybrid and other funds

Personal Background:

Joined Huashang Fund in 2015, serving successively as Industry Researcher, Assistant Fund Manager, and Fund Manager. As of the end of 2025, she has over 10 years of securities industry experience (including 6.3 years in securities research and 4.2 years in securities investment).

Investment Style:

Xiao Zhang at Huashang Fund specializes in tracking industry prosperity changes and demand recovery progress. She aims to identify both sector-leading stocks and value stocks within her focus areas.

Through long-term research practice, Xiao Zhang has a clear investment philosophy. She categorizes companies into two main types: sector stocks and value stocks. For sector stocks, she uses a top-down approach based on industry prosperity, selecting sub-industries benefiting from policy support within high-growth sectors aligned with social development trends. She verifies these through upstream and downstream analysis and financial data logic, positioning her investments at appropriate times. For value stocks, she primarily adopts a bottom-up approach, focusing on performance certainty, management stability, and valuation matching, with a particular emphasis on competitive barriers.

Investment Outlook:

Xiao Zhang states that innovative drugs have shifted from BD narratives to real clinical data storytelling. Overseas clinical data for major products are emerging, continuing to drive the development of domestic innovative drugs. The CXO sector appears to have established a turning point based on order forecasts this year, with ongoing performance and valuation recovery across the industry chain.

Message to Investors:

Stay true to your original intention and live up to your trust.

Wei Sun

Master’s in Science, King’s College London

Fund Manager of Huashang Flexible Allocation Healthcare & Life Science Hybrid Fund

Fund Manager of Huashang Shengshi Growth Hybrid and other funds

Personal Background:

Joined Huashang Fund in 2016, serving successively as Industry Researcher, Assistant Fund Manager, and Fund Manager. As of the end of 2025, she has 9.7 years of securities experience (including 6.8 years in securities research and 2.9 years in securities investment).

Investment Style:

Wei Sun’s investment scope covers pharmaceuticals, healthcare, consumer technology, and cyclical growth sectors. Her core philosophy is “Identify cyclical bottom assets and find good, undervalued companies,” matching cyclical and counter-cyclical assets to find resilient growth opportunities.

In cyclical investments, she selects companies with strong competitiveness in industries experiencing rising prosperity—these companies often outperform industry averages in performance growth, leading to faster valuation increases. In counter-cyclical investments, she seeks assets showing early signs of improvement but whose performance has yet to fully reflect this, often in undervalued positions with good quality and high resilience, capable of delivering significant returns during economic recovery or industry rebound.

Investment Outlook:

Wei Sun expects the innovative drug sector to continue its upward trend in 2026, driving industry chain synergy and recovery, with earnings growth further supported by year-round performance realization, ongoing fundamental improvements, and policy benefits. The metals and minerals sector’s strong performance is driven by supply-demand improvements, policy support, and new demand growth, with high industry prosperity expected to persist.

Message to Investors:

Remain true to your original aspiration and persevere to achieve long-term goals.

Chen Xiaoqiong

Master’s from Peking University

Fund Manager of Huashang New Energy Vehicles Hybrid Fund

Fund Manager of Huashang High-End Equipment Manufacturing Equity Fund

Personal Background:

Joined Huashang Fund in 2015, serving as Industry Researcher, Assistant Fund Manager, and Fund Manager. As of 2025, she has 10.3 years of securities experience (including 9.4 years in securities research and 0.9 years in securities investment).

Investment Style:

Chen Xiaoqiong focuses on high-end manufacturing and new energy industry chains. She firmly believes that “deep research is the cornerstone of navigating market fluctuations,” and excels at accurately grasping industry trends and stock values.

She typically analyzes industry ecosystems through the supply chain, focusing on segments with industry trends, policy support, and technological progress. She identifies core competitive advantages of companies and dynamically assesses industry beta and stock alpha resonance, aiming for high precision and steady growth amid market volatility.

Investment Outlook:

Chen Xiaoqiong expects continued progress in AI models, power infrastructure, energy storage, lithium batteries, and solid-state batteries. She will keep a close eye on these areas, actively seeking investment opportunities and high-quality companies with high certainty.

Message to Investors:

Together, ride the wave of industry trends and witness the rise of China’s high-end manufacturing.

Peng Wu

Master’s in Science, Fudan University

Fund Manager of Huashang Leading Advantage Hybrid Fund

Fund Manager of Huashang High-End Equipment Manufacturing Equity Fund

Personal Background:

Graduated with a master’s in microelectronics and solid-state electronics. Joined Huashang Fund in 2021, serving as Electronic Industry Researcher, Fund Manager. As of 2025, she has 9.3 years of securities experience (including 8.4 years in securities research and 0.9 years in securities investment).

Investment Style:

Peng Wu specializes in research and investment in the technology sector, based on solid industry research. She is skilled at accurately identifying genuine industry growth opportunities amid numerous tech hotspots and trends. She emphasizes pre-judging industry developments, understanding all segments deeply, and observing subtle changes on the front lines of industry. She believes that in industry mainlines, it’s crucial to distinguish primary and secondary contradictions over different periods and to capture these shifts sharply. In top-down stock selection, she strives to precisely select the best logical and performance-driven targets, the true “alpha.”

Investment Outlook:

Peng Wu believes that the next five years will continue to see innovation and investment opportunities in AI. Overseas AI remains hot, while domestic AI is actively breaking through along the entire industry chain—from equipment to advanced processes, chips, and models—achieving notable results. She focuses on the growth potential of semiconductor equipment driven by advanced processes and storage expansion cycles. On the application side, she is interested in large tech companies’ 2C traffic monetization and 2B inflation-related opportunities, as well as the value reshaping brought by private data moats and multi-modal capabilities.

Message to Investors:

Ride the wave of intelligent technology and explore the unknown to start anew.

(Edited by: Xu Nannan)

Keywords: